Medication Adherence: What Can We Do to Help Patients Stick to Therapy Lois Eldred, DrPH, MPH Special Projects of National Significance HIV/AIDS Bureau,

Slides:



Advertisements
Similar presentations
Incorporating Brief Safer Sex Interventions at HIV Outpatient Clinics Partnership for Health The Action of One, The Partnership of Two, The Power of Many.
Advertisements

Coordinating Care Across Funded Providers to Support Retenion in Care: The In+Care Campaign in RI. Aadia Rana, MD Assistant Professor of Medicine Miriam.
Washington D.C., USA, July 2012www.aids2012.org Access to HCV treatment for people with HIV/HCV Professor Gregory Dore Viral Hepatitis Clinical Research.
Intervening to Improve Adherence – What do we Know? Conall O’Cleirigh, Ph.D. Associate Director Behavioral Medicine, Department of Psychiatry.
ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Adherence.
ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis The Role of the Nurse.
ADHERENCE Patrick Desmet HIV / Therapycounselor. 1. What is adherence and why is it important? 2. The factors that influence adherence? 3. How can we.
Adherence Works In 1998, knew missed doses led to resistant virus. Since 1998, studies have demonstrated that adherence leads to lower viral loads, decreased.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Adherence Interventions to Improve HIV Treatment Outcomes David R Bangsberg Massachusetts General Hospital Center for Global Health Harvard Medical School.
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
Promoting Adherence in Children. What are the challenges faced by children that interfere with ART adherence? B ased on your knowledge and experience,
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Salvage Antiretroviral Therapy Guiding Principles, Strategies and the Role of Resistance Testing.
The Future of Health Care for Older People: Will the Disadvantaged by Left Behind? Chad Boult, MD, MPH, MBA Professor and Director Lipitz Center for Integrated.
Unit 10 HIV Care and ART: A Course for Physicians
2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.
+ Module Four: Patient/Family Education and Self-Management At the end of this module, the participant will be able to: Describe three learning needs of.
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
F/C AETC Faculty HIV HCV Thursday, March 12, 2015 | 1:30pm EDT Medical Facilitator/Didactic Presenter Todd S. Wills, MD University of South Florida Case.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
1 Lecture 9: Adherence in ARV Therapy delivered by Dr. Ndwapi Ndwapi, BHP KITSO AIDS Training Program.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
M. Ekstrand 1,2,3, A. Shet 2,4, S. Chandy 4, G. Singh 4, R. Shamsundar 4, V. Madhavan 5, S. Saravanan 5, N. Kumarasamy 5 1 University of California, San.
Addressing adherence challenges – what does the evidence say? Dr Catherine Orrell Desmond Tutu HIV Foundation November 2013.
The Effectiveness of generic Highly Active Antiretroviral Therapy for the treatment of HIV infected Ugandan children Presenter: Linda Barlow-Mosha MD,
Results Compliance with Breast Cancer Screening Guidelines in the HIV Clinic: A Quality Improvement Tool E. Patrozou M.D., E. Christaki M.D., L. Hicks.
What Does Research Tell Us? Care Manager Roles in Depression Care.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
Providing Treatment, Restoring Hope Secondary Prevention as part of HIV Clinical Care Martine Etienne, MPH, DrPH University of Maryland School of Medicine.
Adherence Preparing to start ARVs Dr. Kevin M Harvey MBBS, MPH (UWI), Dip. ID (Lon.) Treatment care and support 2006.
Assessing Your Clients for Adherence: A Real World Approach Sharon Mannheimer, MD Harlem Hospital Center Treatment Adherence Network Meeting February 27,
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
Michael J. Mugavero, MD, MHSc Associate Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Elements of the Care Continuum FORMATTED:
Drug Adherence and Strategies for Compliance Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine
Adherence to HAART. Adherence Summary Adherence is the Achilles Heel of HAART Adherence requires education, a shared negotiation, & the optimal regimen.
1 Pediatric ARV adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Using Multiple Data Sources to Understand Variable Interventions Bruce E. Landon, M.D., M.B.A. Harvard Medical School AcademyHealth Annual Research Meeting.
1/11/01 Pediatric trials for ARV experienced children Coleen K. Cunningham Epidemiology of treatment experience in pediatrics How does the smaller number.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
BUILDING THE BEST RELATIONSHIP WITH YOUR CLINIC/HEALTH CARE PROVIDERS 1.
Better Patient Adherence: Why patients don’t adhere and what we can do about it (maybe) Frank Doyle, PhD RCSI Royal College of Surgeons in Ireland Coláiste.
1 Retention: Partners Make It Happen March 22, 2012 and March 29, 2011 For Audio: Dial-in#: Participant Code: #
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.
Learning objectives Review HIV treatment goals
ADDRESSING THE ACHILLES’ HEEL OF HIV TREATMENT SUCCESS José M
Viral Suppression at the First Integrated Methadone and Antiretroviral Therapy Program for People who Inject Drugs in sub-Saharan Africa Dar es Salaam,
Vancouver, British Columbia, Canada
CIIS Implementation in Progress Mari-Lynn Drainoni, PhD, MEd
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Simple assessments of adherence to antiretorviral therapy predict virologic failure in HIV+ patients in Lusaka, Zambia Ronald A. Cantrell, MPH University.
Introduction to Clinical Pharmacy
Adherence to ART: Why is it so important? 1.
Adetunji Adejumo, MD; Cynthia Lee MA; Sharon Mannheimer, MD
VL patient support: General education at different levels
Adherence to Medical Regimens
Elements of the Care Continuum
T . P. MHEMBERE: BSc Pharm Hons (Zim), MPH (UK)
Interventions to Improve Adherence
Baseline Data and Predictors of Adherence in Patients on Antiretroviral Therapy in Maun General Hospital [MGH], Maun, Botswana Nwokike J.I. [B.Pharm,
Retention: What It Means for You
Presentation transcript:

Medication Adherence: What Can We Do to Help Patients Stick to Therapy Lois Eldred, DrPH, MPH Special Projects of National Significance HIV/AIDS Bureau, HRSA

Viral Suppression in Clinical Practice Lucas, Annals Intern Med 1999

Adherence Critical to Care Nonadherent patients with: u Increased mortality from HIV – OR 1.16 ( ) / 10%  adh 1 u Lower CD4 count increase –+ 6 versus +83 cell/ml increase 2 u Increased hospital days – 12.9 versus 2.5 hosp. days / 1000 days F/U 2 1 Hogg, 7th CROI, Paterson, Ann Intern Med, 2000

How much adherence is enough? Paterson, Ann Intern Med, 2000

Viral Load by Adherence Arnsten, 7th CROI, 2000

Viral load and adherence (MEMS) Mostly women and minorities viral load <100,000 copies/ml, ARV naive Thompson M, et al. XIII IAC, Durban Abstract 1129

Measuring Adherence u No gold standard u Use what is practical –Patient report will overestimate % –Pharmacies can be your friend –Electronic monitoring in selected cases, especially if it will help the patient –Drug levels not practical for adherence monitoring

Factors in Adherence

Predictors of Adherence: Patient u Understanding of the regimen u Alcohol/drug use u Depression u Appointment keeping u Health beliefs and attitudes u Perception of control (self efficacy) u Social support

Adherence and Illicit Drug Use Adapted Cheever, ICAAC, 1999

Drug Abuse Treatment Works 1 OR 1.88 ( ) 2 OR 4.91 ( ) Moatti, AIDS, 2000

Health Beliefs and Attitudes u Associated with antiretroviral (ARVs) use –ARVs will help me have fewer symptoms of HIV –ARVs will help me live longer u Associated with adherence –Medications will often fit into daily routine –If don’t take right, resistance will develop Paterson, Abs 92; Kaplan, Abs 96; Wenger, Abs 98; 6th CROI, 1999; Cheever, Abs 591, 39th ICAAC, 1999

Interventions to Improve Adherence u Barriers to adherence –Differ among patients –Vary over time u Principles of interventions –Multifaceted –Repetitive –Initiated prior to resistance developing

Self Efficacy Counseling to Improve Adherence u Randomized, controlled trial u Intervention: –Counseling to increase self efficacy –Strategies to increase adherence –Association of adherence and resistance –Telephone number for questions Tuldra, JAIDS 2000

Self Efficacy Counseling to Improve Adherence Tuldra, JAIDS 2000

Factors in Adherence

Adherence: Treatment Regimen u Number of doses, medications, pills u Length of time on therapy u Dietary restrictions u Side effects

Side Effects Impact Adherence Arnsten, 7th CROI, 2000

Factors in Adherence

Medical System u Team support and interventions u Doctor- Patient relationship –Trust / satisfaction u Patient education –Appointment reminders –Multiple and varied reinforcers u Accessibility of appointments, medication –Child care / child friendly environment –Transportation

Engagement in Care u Convenience Sample of 707 outpatients u Engagement in care: Interaction with health care provider (13 item scale) –Listens to me –Cares about me –Respects me –Spends enough time with me –Includes me in decision making Bakken, AIDS Patient Care and STDs, 2000

Non-engaged Patients u More likely to be current/past injection drug users (p=0.002) u Nonadherent with –Medication taking –Medical appointments –Following medical advice u Not associated: type of provider, sex, race Bakken, AIDS Patient Care and STDs, 2000

Satisfaction with Information p=0.02 Tuldra, 7th Euro. Conf. Clin. Aspect. And Tx of HIV, 1999

Asking about Adherence: What works Steele, J Fam Pract 1990 “You’re gaining weight. You must be taking your medicine okay.” 0% “Any problems with your medicines?”63% “Almost everyone misses medicines some of the time. In the last (week/month) how many doses of medicine do you think you’ve missed?” “Tell me exactly how you take your medicines.” 80%

Asking About Adherence u Permission for missed dose: Almost everyone misses medicines some of the time. u Specific questioning: In the last (week/month) how many doses of medicine do you think you’ve missed? u Verify understanding of regimen: Tell me exactly how you take your medicines.

Interventions to Improve Adherence: Background u Clinicians play a specific role and significant role in initiating and monitoring adherence u Adherence research and other diseases focuses primarily on physicians u Most HIV adherence interventions involve a team of providers

Improving Access to Care u >1/3 of patients in U.S. sample (HCSUS) went without medical care due to:1 – Need for money for food/clothing/housing – Lack of transportation – Inability to get time off from job/work – Feeling too sick u Caring for others: Putting off care 2 – Women OR 1.6 ( ) – Having child in household OR 1.8 ( ) 1 Cunningham, Med Care 1999, 2 Stein Am J of Pub Health 2000

Support Services and Retention in Care Sherer R, AIDS Care, 2002 n= % increase in regular visits (>2/year) in an urban clinic with support services,

Directly Observed Therapy DOT = directly observed therapy (incarcerated cohort) SAT = self-administered therapy (free clinic cohort) 4 Fischl 7th CROI, SF, Abs 71

Interventions: Incentives Work Chaisson, JAIDS, 1996

Incentive to Improve Adherence u Randomized, controlled trial –MEMS device and AZT plasma levels u Intervention –Cue dose training –Feedback from MEMS device –Cash ($2/correct dose up to $10/day, $280 max.) Rigsby, J Gen Intern Med 2000

Incentive to Improve Adherence Rigsby, J Gen Intern Med 2000

SPNS/HRSA Initiative: Adherence u 14 Projects with varying adherence interventions ( ) u Common core data evaluated among the projects u Evaluation Center: New York Academy of Medicine; Center for Adherence Support and Education (CASE)

CASE Findings u “readiness” component helps client maintain high levels of adherence u Interventions based on Prochaska’s stages of change helpful over 6 months u No direct relationship between the intensity of encounters and improvement in adherence u Specific support and clinical services have positive impact over time

Medication Support Versus Standard of Care: Johns Hopkins HIV Clinic u Nurse Education u Case Management u Peer Advocacy u Group Education u Results: High users of readiness program more likely to achieve improved viral suppression (< 50)

Self Efficacy Counseling to Improve Adherence VariableOdds RatioCIp value Self efficacy – Intervention group – Effort Index – Multivariate Analysis: Adh. >95% at 48 wks Tuldra, JAIDS 2000

Adherence: Conclusions u Adherence is critical for long term success of HAART u Interventions must be maintained over time u Barriers differ among patients and over time interventions must be patient-tailored u Adherence interventions are now a standard part of quality HIV care

Adherence: Where do we go from here? u Needs assessment of readiness and active interventions to promote self-efficacy for taking medications u Collaborative approach in timing the initiation of medication u Group support and education is a powerful tool Self-management Programs

Adherence: Where do we go from here? u Use experiences with other chronic disease self-management programs u Cost effectiveness must be demonstrated as adherence interventions are integrated into practice

For more HIV-related resources, please visit